These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6927281)

  • 1. Penetration of moxalactam and cefazolin into atrial appendage after simultaneous intramuscular or intravenous administration.
    Polk RE; Smith JE; Ducey K; Lower RR
    Antimicrob Agents Chemother; 1982 Aug; 22(2):201-3. PubMed ID: 6927281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penetration of moxalactam and cefazolin into bone following simultaneous bolus or infusion.
    Polk R; Hume A; Kline BJ; Cardea J
    Clin Orthop Relat Res; 1983; (177):216-21. PubMed ID: 6222858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative penetration of latamoxef (moxalactam) and cefazolin into human knee following simultaneous administration.
    Hume AL; Polk R; Kline B; Cardea J
    J Antimicrob Chemother; 1983 Dec; 12(6):623-7. PubMed ID: 6662840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects.
    Scheld WM; Spyker DA; Donowitz GR; Bolton WK; Sande MA
    Antimicrob Agents Chemother; 1981 Apr; 19(4):613-9. PubMed ID: 6454387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cefazolin and moxalactam pharmacokinetics after simultaneous intravenous infusion.
    Polk RE; Kline BJ; Markowitz SM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):576-9. PubMed ID: 6459759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A comparison of the penetration characteristics of latamoxef and cephalothin into the right atrial appendage and pericardial fluid of adult patients undergoing open-heart surgery].
    Sato Y; Kanazawa H; Okazaki H; Kosuge T; Imaizumi K; Eguchi S
    Jpn J Antibiot; 1984 Apr; 37(4):671-9. PubMed ID: 6471383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers.
    Srinivasan S; Fu KP; Neu HC
    Antimicrob Agents Chemother; 1981 Feb; 19(2):302-5. PubMed ID: 6214989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-dose antibiotic prophylaxis for biliary surgery. Cefazolin vs moxalactam.
    Kellum JM; Duma RJ; Gorbach SL; Sugerman HJ; Haynes BW; Gervin A; Newsome HH
    Arch Surg; 1987 Aug; 122(8):918-22. PubMed ID: 3115228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative pharmacokinetics of ceftazidime and moxalactam.
    Tjandramaga TB; Van Hecken A; Mullie A; Verbesselt R; De Schepper PJ; Verbist L
    Antimicrob Agents Chemother; 1982 Aug; 22(2):237-41. PubMed ID: 6765416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moxalactam--absorption, excretion, distribution, and metabolism.
    Shimada J; Ueda Y
    Rev Infect Dis; 1982; 4 Suppl():S569-80. PubMed ID: 6218568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled, comparative study of moxalactam and cefazolin for prophylaxis of abdominal hysterectomy.
    Berkeley AS; Hayworth SD; Hirsch JC; Freedman KS; Ledger WJ
    Surg Gynecol Obstet; 1985 Nov; 161(5):457-61. PubMed ID: 3901359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative penetration of cefonicid and cefazolin into the atrial appendage and pericardial fluid of patients undergoing open-heart surgery.
    Dudley MN; Nightingale CH; Drezner AD; Low HB; Quintiliani R
    Antimicrob Agents Chemother; 1984 Sep; 26(3):347-50. PubMed ID: 6334490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of moxalactam in elderly subjects.
    Andritz MH; Smith RP; Baltch AL; Griffin PE; Conroy JV; Sutphen N; Hammer MC
    Antimicrob Agents Chemother; 1984 Jan; 25(1):33-6. PubMed ID: 6703682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lack of inactivation of tobramycin by cefazolin, cefamandole, and moxalactam in vitro.
    Earp CM; Barriere SL
    Drug Intell Clin Pharm; 1985 Sep; 19(9):677-9. PubMed ID: 4042863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefazolin bolus and continuous administration for elective cardiac surgery: improved pharmacokinetic and pharmacodynamic parameters.
    Adembri C; Ristori R; Chelazzi C; Arrigucci S; Cassetta MI; De Gaudio AR; Novelli A
    J Thorac Cardiovasc Surg; 2010 Aug; 140(2):471-5. PubMed ID: 20570290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single- and multiple-dose pharmacokinetics of moxalactam in normal subjects.
    Israel KS; Black HR; Brier GL; Wolny JD; DeSante KA
    Antimicrob Agents Chemother; 1982 Jul; 22(1):94-102. PubMed ID: 6214998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum kinetics of intraperitoneal moxalactam.
    Fry DE; Trachtenberg L; Polk HC
    Arch Surg; 1986 Mar; 121(3):282-4. PubMed ID: 3947227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
    Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
    Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and bioavailability of cefazolin in horses.
    Sams RA; Ruoff WW
    Am J Vet Res; 1985 Feb; 46(2):348-52. PubMed ID: 3994100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moxalactam penetration into normal heart valve, cardiac vegetations, and myocardium in relation to protein binding and physiological distribution spaces.
    Fitzpatrick BC; Gengo FM; Schentag JJ
    Antimicrob Agents Chemother; 1984 Aug; 26(2):228-30. PubMed ID: 6486765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.